RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Guo, Fang ^a   Mead, Jennifer ^a   Aliya, Nishat ^a   Wang, Lijuan ^a   Cuconati, Andrea ^b   Wei, Lai ^c   Li, Kui ^d   Block, Timothy M ^a,b   Guo, Ju Tao ^a   Chang, Jinhong ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HEPATITIS B FOUNDATION   (United States)

^c PEKING UNIVERSITY   (China)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'2' (4 AMINOPHENYL) [2,5' BI 1H BENZIMIDAZOL] 5 AMINE; ANTIVIRUS AGENT; BETA INTERFERON; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; PATTERN RECOGNITION RECEPTOR; RECEPTOR; RIG I LIKE RECEPTOR; RO 907501; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNE RESPONSE; INNATE IMMUNITY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

AMINES; ANTIVIRAL AGENTS; BENZIMIDAZOLES; BLOTTING, WESTERN; CELL LINE; DEAD-BOX RNA HELICASES; DRUG SYNERGISM; ENZYME ACTIVATION; GENE EXPRESSION; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; LUCIFERASES; MOLECULAR STRUCTURE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLY I-C; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 3; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 84867055703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042583     Document Type: Article

References (43)

1. Brennan K, Bowie AG, (2010) Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 13: 503-507.
2. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672-676.
3. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
4. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
5. Bray M, (2005) Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol 17: 399-403.
6. Samuel MA, Diamond MS, (2006) Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80: 9349-9360.
7. Clyde K, Kyle JL, Harris E, (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418-11431.
8. Kanzler H, Barrat FJ, Hessel EM, Coffman RL, (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13: 552-559.
9. O'Neill LA, Bryant CE, Doyle SL, (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61: 177-197.
10. Guo H, Jiang D, Ma D, Chang J, Dougherty AM, et al. (2009) Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol 83: 847-858.
11. Pockros PJ, Jeffers L, Afdhal N, Goodman ZD, Nelson D, et al. (2007) Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 45: 569-578.
12. Horsmans Y, Berg T, Desager JP, Mueller T, Schott E, et al. (2005) Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 42: 724-731.
13. Fidock MD, Souberbielle BE, Laxton C, Rawal J, Delpuech-Adams O, et al. (2011) The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691). Clin Pharmacol Ther 89: 821-829.
14. Damm J, Wiegand F, Harden LM, Gerstberger R, Rummel C, et al. (2012) Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the Toll-like receptor 7 agonist imiquimod. Neuroscience 201: 166-183.
15. O'Neill LA, Bowie AG, (2010) Sensing and signaling in antiviral innate immunity. Curr Biol 20: R328-333.
16. Wang N, Dong Q, Li J, Jangra RK, Fan M, et al. (2010) Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent. J Biol Chem 285: 6080-6090.
17. Elco CP, Guenther JM, Williams BR, Sen GC, (2005) Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J Virol 79: 3920-3929.
18. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, et al. (2001) A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem 276: 30178-30182.
19. Ermolaeva MA, Michallet MC, Papadopoulou N, Utermohlen O, Kranidioti K, et al. (2008) Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 9: 1037-1046.
20. Schrofelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, et al. (2009) Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem J 421: 473-482.
21. Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I, (2009) Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 85: 664-672.
22. Steer SA, Moran JM, Christmann BS, Maggi LB Jr, Corbett JA, (2006) Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. J Immunol 177: 3413-3420.
23. Stewart MJ, Kulkarni SB, Meusel TR, Imani F, (2006) c-Jun N-terminal kinase negatively regulates dsRNA and RSV induction of tumor necrosis factor- alpha transcription in human epithelial cells. J Interferon Cytokine Res 26: 521-533.
24. Mitchell D, Olive C, (2010) Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases. Mol Immunol 47: 2065-2073.
25. Balachandran S, Beg AA, (2011) Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLoS Pathog 7: e1002165.
26. Li K, Chen Z, Kato N, Gale M Jr, Lemon SM, (2005) Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280: 16739-16747.
27. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, et al. (2004) Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11: 1060-1067.
28. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
29. Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, et al. (2011) Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Cell Microbiol 13: 1907-1919.
30. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
31. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
32. Thiel V, Weber F, (2008) Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev 19: 121-132.
33. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA, (2007) Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81: 5518-5526.
34. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, et al. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366-1373.
35. Ireton RC, Gale M Jr, (2011) RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses 3: 906-919.
36. Chang YC, Madkan V, Cook-Norris R, Sra K, Tyring S, (2005) Current and potential uses of imiquimod. South Med J 98: 914-920.
37. Loo YM, Gale M Jr, (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
38. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ.
39. Bohrmann B, Adrian M, Dubochet J, Kuner P, Muller F, et al. (2000) Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates. J Struct Biol 130: 232-246.
40. Conforti R, Ma Y, Morel Y, Paturel C, Terme M, et al. (2010) Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer Res 70: 490-500.
41. Salaun B, Zitvogel L, Asselin-Paturel C, Morel Y, Chemin K, et al. (2011) TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res 71: 1607-1614.
42. Guo JT, Hayashi J, Seeger C, (2005) West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79: 1343-1350.
43. Chang J, Wang L, Ma D, Qu X, Guo H, et al. (2009) Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses. Antimicrob Agents Chemother 53: 1501-1508.